Horizon Licenses Harvard Gene Editing IP | GenomeWeb

NEW YORK (GenomeWeb News) – Horizon Discovery announced today that it has licensed non-exclusive rights to Harvard University's intellectual property covering gene-editing technology.

The Cambridge, UK-based firm said the license covers the commercialization of products that utilize Harvard's CRISPR gene-editing technology for research use. CRISPR is an RNA-guided gene editing system that can introduce either a targeted double strand break or single strand nick in the genome of mammalian cells.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.